Literature DB >> 21551087

The exchangeable calcium pool: physiology and pathophysiology in chronic kidney disease.

Markus Pirklbauer1, Gert Mayer.   

Abstract

Excessive soft tissue and vascular calcifications are typical complications of chronic kidney disease (CKD) and disorders of phosphate homeostasis are considered to be a major contributor to the pathogenesis. However, at least in some individuals, calcium administration also increases the risk, and furthermore, it is widely accepted that there is a link between bone disease and vascular pathology. In this review, we discuss the role of the bone exchangeable calcium pool (ECP) in the acute regulation of the serum calcium concentration (Ca(s)) in health and CKD. This pool is able to buffer an acute calcium load as well as to maintain a stable Ca(s) during acute calcium deprivation. Indeed, the minute-to-minute regulation of Ca(s) appears to depend exclusively on this mechanism without any obvious contribution of other factors like parathyroid hormone, which nonetheless define the Ca(s) steady state set point. It is tempting to speculate that a reduction of the bone ECP plasticity in some patients with CKD leads to short-lasting increases in Ca(s) above the individual mid- to long-term set point as observed during haemodialysis or after the ingestion of calcium-containing phosphate binders. This could contribute to and partially explain the propensity of these subjects to develop extraosseous calcifications. An improved understanding of the processes involved and the availability of new techniques to assess the capacity of this pool, at least in dialysis patients, will make this area an attractive target for new investigations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21551087     DOI: 10.1093/ndt/gfr207

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

1.  Intradialytic Calcium Kinetics and Cardiovascular Disease in Chronic Hemodialysis Patients.

Authors:  Markus Pirklbauer; Lisa Fuchs; Ramona Heiss; Thomas Ratschiller; Gert Mayer
Journal:  Blood Purif       Date:  2020-07-24       Impact factor: 2.614

2.  Acute severe hypercalcemia after traumatic fractures and immobilization in hypophosphatasia complicated by chronic renal failure.

Authors:  Michael P Whyte; Rattana Leelawattana; William R Reinus; Chang Yang; Steven Mumm; Deborah V Novack
Journal:  J Clin Endocrinol Metab       Date:  2013-09-24       Impact factor: 5.958

Review 3.  Renale osteodystrophie.

Authors:  Daniel Cejka
Journal:  Wien Med Wochenschr       Date:  2013-05-09

4.  Calcium fluxes at the bone/plasma interface: Acute effects of parathyroid hormone (PTH) and targeted deletion of PTH/PTH-related peptide (PTHrP) receptor in the osteocytes.

Authors:  Christopher Dedic; Tin Shing Hung; Alan M Shipley; Akira Maeda; Thomas Gardella; Andrew L Miller; Paola Divieti Pajevic; Joseph G Kunkel; Alessandro Rubinacci
Journal:  Bone       Date:  2018-07-24       Impact factor: 4.398

5.  Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system.

Authors:  Marie-Eve Muller; Valentina Forni Ogna; Marc Maillard; Candice Stoudmann; Carole Zweiacker; Christiane Anex; Grégoire Wuerzner; Michel Burnier; Olivier Bonny
Journal:  Pflugers Arch       Date:  2015-06-20       Impact factor: 3.657

Review 6.  Acidosis and Urinary Calcium Excretion: Insights from Genetic Disorders.

Authors:  R Todd Alexander; Emmanuelle Cordat; Régine Chambrey; Henrik Dimke; Dominique Eladari
Journal:  J Am Soc Nephrol       Date:  2016-07-28       Impact factor: 10.121

7.  Calcium Mass Balance during Citrate Hemodialysis: A Randomized Controlled Trial Comparing Normal and Low Ionized Calcium Target Ranges.

Authors:  Jakob Gubensek; Alesa Orsag; Rafael Ponikvar; Jadranka Buturovic-Ponikvar
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

8.  Upregulated microRNA‑330‑3p promotes calcification in the bicuspid aortic valve via targeting CREBBP.

Authors:  Rui Zheng; Hao Liu; Jiaxi Gu; Buqing Ni; Haoliang Sun; Yaojun Guo; Chen Su; Keshuai He; Junjie Du; Yongfeng Shao
Journal:  Mol Med Rep       Date:  2020-07-06       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.